MAGT1 and Parkinson disease: Lin et al. [19] observed that 6-OHDA downregulates MagT1, SLC41A1, and CNNM2 in a PD cell model, and magnesium sulfate supplementation increases their expression in a PD rat model at 14 days post-lesion.